BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11658344)

  • 1. The war on cancer.
    Hawkins P
    Congr Rec (Dly Ed); 1981 Oct; 127(148):S11610-8. PubMed ID: 11658344
    [No Abstract]   [Full Text] [Related]  

  • 2. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 3. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 4. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 5. Annual review: observed deficiencies and suggested corrections.
    Adams MS; Conrad DA
    IRB; 1996; 18(6):1-4. PubMed ID: 11654743
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection of human subjects.
    United States
    Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract]   [Full Text] [Related]  

  • 7. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 9. A look at the bioresearch monitoring program: the agency perspective.
    Brisson EL
    Food Drug Cosmet Law J; 1983 Apr; 38(2):184-9. PubMed ID: 11649578
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 11. Report says institutional review boards are conducting inadequate reviews.
    Maloney DM
    Hum Res Rep; 1998 Sep; 13(9):1-2. PubMed ID: 11660603
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA revises informed consent regulations for emergency research.
    Menasché A; Levine RJ
    IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
    [No Abstract]   [Full Text] [Related]  

  • 13. An even safer safety net.
    Prentice E
    Hastings Cent Rep; 1997; 27(3):46. PubMed ID: 11644996
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical and psychological experimentation on California prisoners.
    Herch F; Flower R
    Univ Calif Davis Law Rev; 1974; 7():351-84. PubMed ID: 11661107
    [No Abstract]   [Full Text] [Related]  

  • 15. IRBs and epidemiologic research: how inappropriate restrictions hamper studies.
    Cann CI; Rothman KJ
    IRB; 1984; 6(4):5-7. PubMed ID: 11649562
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of clinical research: who's protecting who from what?
    Petricciani JC
    Food Drug Cosmet Law J; 1979 Apr; 34(4):205-7. PubMed ID: 11661718
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of FDA, IRBs and regulations.
    Petricciani JC
    IRB; 1981 Dec; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract]   [Full Text] [Related]  

  • 18. Is this a job for the IRB? The case of the ELISA assay.
    Holder AR
    IRB; 1985; 7(6):7-8. PubMed ID: 11649689
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 20. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG
    IRB; 1988; 10(3):6-7. PubMed ID: 11651911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.